Tennis Legend John McEnroe Tells Men to 'Get Serious' About Prostate Cancer

Teaming With Health Organizations To Make Men Aware of New Guidelines: Talk
With Doctor About Prostate Cancer At Age 40

PHILADELPHIA, Aug. 27 /PRNewswire-FirstCall/ -- Seven-time grand slam winner
John McEnroe, whose father was diagnosed with prostate cancer in 2006, is
providing his voice and image to a new campaign that promotes recently updated
prostate-cancer screening guidelines.

One in six men in the United States will be diagnosed with prostate cancer(1)
during their lifetime, and prostate cancer is the second-leading cause of
cancer death among American men.(2) The updated American Urological
Association (AUA) guidelines have lowered the age (from 50 to 40) (3) for when
a man should start being monitored for Prostate Cancer, which includes talking
to a doctor about the prostate-specific antigen test (PSA), a simple blood
test.(4)

"When my dad was diagnosed with prostate cancer, it was a big wake up call for
me. I was really surprised by the prevalence of this disease," said McEnroe
who turned 50 this past February. "The new AUA guidelines fit my philosophy
to be proactive about health. I am hoping my story and involvement in this
campaign may help a few more guys start managing their risk."

The campaign includes a widely distributed print advertisement that debuts in
September. This effort is led by Stand Up To Cancer(TM), a program of the
Entertainment Industry Foundation, as well as the American Urological
Association, GlaxoSmithKline (NYSE: GSK), Men's Health Network, Prostate
Cancer Foundation and the Prostate Conditions Education Council. More
information is available at www.ProstateCancerWatch.com.

About Stand Up to Cancer
The Stand Up To Cancer(TM) (SU2C) movement raises funds to hasten the pace of
groundbreaking translational research that can get new therapies to patients
quickly and save lives. In the Fall of 2007, a group of women whose lives
have all been affected by cancer in profound ways began working together to
marshal the resources of the media and entertainment industries in the fight
against the disease. SU2C was formally launched on May 27, 2008. More
information is available at www.SU2C.org.

About the American Urologic Association Foundation
Originally established in 1987, the American Urologic Association Foundation
(AUAF) is the premier provider and resource for the most current,
comprehensive and reliable urologic health information. AUAF advocates and
educates to empower physicians and the public to progress toward the highest
quality prevention, detection and treatment of urologic diseases. With the
support and strength of more than 16,000 physician members of the American
Urological Association, the AUAF strives to make certain that those who suffer
from urologic conditions can enjoy the benefit of the highest level of care
possible. More information is available at www.AUAFoundation.org.

About the Prostate Cancer Foundation
The Prostate Cancer Foundation is the world's largest philanthropic source of
support for prostate cancer research focused on discovering better treatments
and a cure for prostate cancer. Founded in 1993, the PCF has raised more than
$370 million and provided funding to more than 1,500 research projects at
nearly 200 institutions worldwide. The PCF also advocates for greater
awareness of prostate cancer and more federal research funds. PCF advocacy
has helped produce a 20-fold increase in government funding for prostate
cancer since 1994. More information is available at www.PCF.org.

About the Prostate Conditions Education Council
A national organization committed to men's health, the Prostate Conditions
Education Council (PCEC) -- formerly the Prostate Cancer Education Council --
is dedicated to saving lives through awareness and the education of men, the
women in their lives, as well as the medical community about prostate cancer
prevalence, the importance of early detection, and available treatment
options, as well as other men's health issues. The Council -- comprised of a
consortium of leading physicians, health educators, scientists and prostate
cancer advocates -- aims to conduct nationwide screenings for men and perform
research that will aid in the detection and treatment of prostate cancer.
More information is available at www.prostateconditions.org.

About Men's Health Network
Men's Health Network (MHN) is a national non-profit organization whose mission
is to reach men and their families where they live, work, play, and pray with
health prevention messages and tools, screening programs, educational
materials, advocacy opportunities, and patient navigation. With a network of
chapters, affiliates, and partners, MHN has a presence in every state and 30
countries. More information is available at www.menshealthnetwork.org.

About GlaxoSmithKline
GlaxoSmithKline -- one of the world's leading research-based pharmaceutical
and healthcare companies -- is committed to improving the quality of human
life by enabling people to do more, feel better and live longer. More
information is available at www.GSK.com.

GlaxoSmithKline funded and helped develop this campaign, including providing
compensation to Mr. McEnroe.

Inquiries: Rob Perry 919-483-2839

References:
1. Prostate Cancer Foundation. About Prostate Cancer. How Common Is
Prostate Cancer? Paragraph 1. Line 1. Available at:
www.prostatecancerfoundation.org/site/c.itIWK2OSG/b.4983495/k.5C76/About_Prostate_Cancer.htm

2. Centers For Disease Control and Prevention. Cancer Prevention And
Control. Cancer Among Men. Leading Cause of Cancer Death Among Men.
Paragraph 2. Line 1. Available at: www.cdc.gov/cancer/dcpc/data/men.htm

3. American Urological Association. Prostate-Specific Antigen Best Practice
Statement: 2009 Update. Page 29. 9. Early detection and risk assessment of
prostate cancer to asymptomatic men 40 years of age or older how wish to be
screened with an estimated life expectancy of more than 10 years. Available
at:
www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/psa09.pdf

4. Prostate Foundation. PSA & DRE Screening. The PSA Blood Test. Paragraph
2. Line 1. Available at:
http://www.prostatecancerfoundation.org/site/c.itIWK2OSG/b.47285/k.CCF1/Detection__Screening.htm.

SOURCE GlaxoSmithKline

Rob Perry for GlaxoSmithKline, +1-919-483-2839